Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Safety is one of the key reasons that Cymerus technology provides an ...
Preclinical Study Will Probe Potency of Cymerus MSCs in Treating IPF
Cynata Therapeutics finalises Cymerus patent to treat adverse reactions ...
Cymerus MSCs治疗骨关节炎的II期临床试验取得新进展-MedSci.cn
Cymerus Stem Cell Therapy for IPF Has Anti-inflammatory Effects in Mice
Cymerus MSCs in Research
Overcoming the Challenges of Manufacturing Therapeutic Mesenchymal Stem ...
Cynata Therapeutics on LinkedIn: Did you know the Cymerus™ technology ...
Cynata Therapeutics to talk stem cell therapies at Proactive’s CEO ...
Cynata Introduces Critical Innovation into MSC Manufacturing | BioInformant
Cynata Therapeutic’s Cymerus™ iPSC-MSC Manufacturing Platform : r ...
#stemcelltherapy #medicaladvancements | Cynata Therapeutics
Cynata's "Major Breakthrough" in MSC Manufacturing - Unlimited ...
Cynata Files New Patent Application for Cymerus™ Technology in Oncology
Meet Ms Janine Rolfe, Cynata’s (ASX:CYP) new Non-Executive Director
CynataのCymerus™プラットフォームテクノロジー - それは何か？ | BioInformant
Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac ...
Cynata Advances Development of Cymerus™ MSCs for the Treatment of Asthma
Cynata Shares Jump as Japan's FUJIFILM Negotiates Deal to Commercialize ...
(PDF) Cymerus™ iPSC-MSCs significantly prolong survival in a pre ...
Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical ...
Cymerus™ MSCs Effective in Preclinical Model of Sepsis
Cynata Therapeutics (ASX:CYP) is advancing Cymerus™️, a proprietary ...
Cynata to expand recruitment criteria in Covid-19 treatment trial
#StemCells have the potential to treat a wide range of illnesses ...
Generating iSPC-derived MSCs with the Cymerus™ Platform - YouTube
Cynata’s Cymerus™ MSCs Effective in Preclinical Model of Diabetic ...
ASX Health Stocks: Big tick for Cynata's stem-cell therapy | Stockhead
CYmerus™ trial reports survival rate in SR-aGvHD | Cynata Therapeutics ...
Advancing MSC-Based Therapies: Overcoming Manufacturing Barriers with ...
Cymerus™ MSC treatment leads to improved recovery of cardiac function ...
Could Cynata's Cymerus™ Platform Be A Tool for the Pandemic?
Cynata Ripe for Strategic Partnerships as Patent for Cymerus™ MSC ...
Kilian Kelly on LinkedIn: Our paper on the use of Cynata Therapeutics ...
Ross Macdonald on LinkedIn: Cynata Therapeutics (ASX:CYP) flags $1m ...
Cynata's Cymerus™ Technology - YouTube
How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform ...
Kilian Kelly on LinkedIn: Great validation for our GvHD product, CYP ...
Cynata's Cymerus™ Technology (Japanese) - YouTube
Cynata Therapeutics (ASX: CYP): Speculative Investment Analysis - The ...
Cynata Announces Japanese Patent Office Decision to Grant Patent for ...
Cynata's Cymerus™ Technology (Chinese) - YouTube
Aussie stem cell research could makes diabetic wounds less troublesome ...
Boston researchers, GSK join to develop pulmonary fibrosis stem cell models
Cynata launches diabetic foot ulcer clinical trial | The West Australian
Cynata Therapeutics, Behind the Scenes with CEO Dr. Ross Macdonald
TechInvest
Can New Manufacturing Platform Reduce "Sky High" Costs of Stem Cell ...
SPECIAL FEATURE - Platform Technologies - Derisking & Transforming Drug ...
Cerberus Vs Chimera
Cynata Therapeutics Limited - Shares in Value
Cynata Therapeutics Ltd to talk stem cell therapies at Proactive’s CEO ...
#ipsc #msc | Kilian Kelly
Freezing Bags Range - CellBios
Positive Data from Cynata MSCs in Second Preclinical Asthma Study ...
Why Cynata is hopeful its COVID treatment trial will succeed where ...
Cynata (ASX:CYP) strengthens its IP position with new Australian patent
WEBINAR: The use of stem cells in acute respiratory distress syndrome ...
Cynata (ASX:CYP) strengthens its IP portfolio with another US patent
Cynata Therapeutics on LinkedIn: Acute Respiratory Distress Syndrome ...
Sharewise | Milsons Point NSW
Patient Enrolment Completed in CYP-006TK Diabetic Foot Ulcer Clinical Trial
Cynata completes final patient visits in pivotal Phase 3 osteoarthritis ...
Cynata Case Study | Plexus Ventures
Treating Diabetes with Live Stem Cells | TekCyte
Cynata’s (ASX: CYP) DFU clinical trial to continue as planned, says DSMB
10 Facts About the Cyrus Cylinder | Asia Society
Cynata unveils promising results in treating graft versus host disease ...
Kilian Kelly on LinkedIn: More great news today here at Cynata, this ...
First Patient Treated in Phase 2 GvHD Trial | BioInformant
Cynata Therapeutics | LinkedIn
#cynata #clinicaltrial #medicalresearch #fundraising #stemcells #msc ...
#advancedtherapiescongress | Mathias Kroll Ph.D. M.B.A. (IMD) GAICD
Cynata Therapeutics (ASX:CYP) 1H20 results & outlook | Finance News Network
#osteoarthritis #clinicaltrial | Cynata Therapeutics
“10 Facts About the Cyrus Cylinder,” Asia Society, accessed April 18 ...
Cyrus The Great British Museum
Stocks of the Hour: NOVONIX, Cynata Therapeutics, Cauldron Energy ...
Cynata Therapeutics (CYYNF): Pioneering Regenerative Medicine Pipelines ...
Discoveries in Biblical Archaeology: Ongoing Saga of Cyrus Cylinder
Cynata Therapeutics on LinkedIn: Cynata has released its Quarterly ...
澳大利亚临床项目进展：干细胞及再生医学技术推动iMSC异体大规模生产 - 知乎
Cynata - ASX Announcement: Trading Halt | Facebook
Cymus (Cymus) - Picture Insect
Cynata's CYP-006TK: A Game Changer for Diabetic Foot Ulcers?
หุ้น CYYNF งบการเงิน 10 ปี พร้อมกราฟ - Finnomena
Pitt Street Research Report On Cynata Therapeutics, Valuation Range A$2 ...
Full article: Industry updates from the field of stem cell research and ...
Testosterone Cypionate Multi Dose Vial at Charli Light blog
Cynata Therapeutics on LinkedIn: CEO Cynata Ross Macdonald was an ...
Cyrus The Great: Fascinating Facts & Accomplishments
Critical Limb Ischemia Treatment Market Size, Growth, Share 2025 – 2031
Are these 4 ASX medical shares set for a healthy 2021?
Cynata’s Stem Cell Therapy Meets All Safety & Efficacy Endpoints in Trial
msemporda: CYNATA
#stemcells #ipsc #celltherapies #advancedtherapies | Cade Hildreth, B.A ...
Cyrus Cylinder 8k PBR Textures Model - TurboSquid 1986725
Phase 2 clinical trial of CYP-001 for treating high risk acute graft ...
Cynata’s paper published in a highly respected peer reviewed journal
#regenmed #regenerativemedicine #celltherapy #stemcell | CCRM Australia
)
